Pulmonary Embolization as the Primary Clinical Manifestation of Intravenous Leiomyomatosis With Intracardiac Extension

2012 ◽  
Vol 94 (3) ◽  
pp. 1012 ◽  
Author(s):  
Chaoji Zhang ◽  
Xingrong Liu ◽  
Guotao Ma ◽  
Heng Zhang ◽  
Chao Wang ◽  
...  
Author(s):  
Rohit Bhoil ◽  
Vijay Thakur ◽  
Yashwant Singh Verma ◽  
Sabina Bhoil ◽  
Ashwani Tomar ◽  
...  

Pathology ◽  
2019 ◽  
Vol 51 ◽  
pp. S160
Author(s):  
O.P. Balisan ◽  
G. Valloso ◽  
L. Cale-Subia

2015 ◽  
Vol 4 (1) ◽  
pp. 179-183
Author(s):  
Aline Tenzer ◽  
Jan Sebastian Wolter ◽  
Stefan Gattenlohner ◽  
Peter Roth ◽  
Ahmed Koshty ◽  
...  

2012 ◽  
Vol 94 (3) ◽  
pp. 1013 ◽  
Author(s):  
Heng Zhang ◽  
Qi Miao ◽  
Jianzhou Liu ◽  
Chao Wang ◽  
Chaoji Zhang ◽  
...  

2010 ◽  
Vol 19 (1) ◽  
pp. 50-52 ◽  
Author(s):  
Taranpreet Singh ◽  
Philip M. Lamont ◽  
Geoffrey R. Otton ◽  
Duncan S. Thomson

2020 ◽  
Vol 09 (01) ◽  
pp. e40-e43
Author(s):  
Yundan Deng ◽  
Bing Song

Abstract Background Intravenous leiomyomatosis is a rare disease. Histologically, intravenous leiomyomatosis is a benign tumor, but its biological behavior can be malignant. The development of intracardiac extensions leads to congestive heart failure and occasionally sudden fatalities. Case Description The cases of three patients treated at our university between 2017 and 2018 were studied retrospectively. Intravenous tumors extending into the right heart system were fully removed without perioperative complications or death. Only one tumor recurrence was observed during the followed-up period. Conclusion The gold standard for the treatment of intravenous leiomyomatosis with intracardiac extension is complete and successful surgical resection.


2017 ◽  
Vol 103 (2) ◽  
pp. e145-e147 ◽  
Author(s):  
Jonathan D. Price ◽  
Constantine Anagnostopoulos ◽  
Alan Benvenisty ◽  
Ravi K. Kothuru ◽  
Sandhya K. Balaram

Sign in / Sign up

Export Citation Format

Share Document